US Patent Issued to DAIICHI SANKYO on June 3 for "Combination of antibody-drug conjugate and immune checkpoint inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,736, issued on June 3, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo).

"Combination of antibody-drug conjugate and immune checkpoint inhibitor" was invented by Tomomi Iwata (Tokyo), Chiaki Ishii (Tokyo), Teiji Wada (Tokyo), Saori Ishida (Tokyo) and Yasuki Kamai (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition and a therapeutic method wherein an antibody-drug conjugate and an immune checkpoint inhibitor are administered in combination, and the antibody-drug conjugate is an antibody-drug conjugate in which a drug-linker represented by the following formula (wherein A represents the connecting position to an antibo...